Metabolite results when a drug is metabolized into a modified form which continues to produce effects. Endogenous variables like age, sex, body composition, genetics, and underlying pathologies have an impact on a given body fluid's metabolome. The activity of an enormous variety of enzymes and transporters responsible for the production, transformation, degradation, and compartmentalization of these small molecules typically keeps the levels of the enormous variety of unique small-molecule metabolites tightly regulated. In the brain, endogenous small molecules are typically present at levels that are tightly controlled.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V30494 | 1-Kestose | 470-69-9 | 1-Kestose is the smallest fructooligosaccharide component that effectively stimulates Faecalibacterium prausnitzii and Bifidobacteria. | |
V53582 | 1-Methoxyphaseollidin | 65428-13-9 | 1-Methoxyphaseollidin, a flavonoid compound, is an inhibitor (blocker/antagonist) of lysoPAF acetyltransferase with IC50 of 48 μM. | |
V72496 | 1-Methyl-L-histidine-d3 | 91037-48-8 | 1-Methyl-L-histidine-d3 is the deuterium labelled form of 1-Methyl-L-histidine. | |
V72493 | 1-Methylguanidine hydrochloride | 21770-81-0 | 1-Methylguanidine HCl is an endogenously produced metabolite. | |
V80785 | 1-Methylguanosine-d3 | 1-Methylguanosine-d3 is a deuterated labeled 1-Methylguanosine. | ||
V82155 | 1-Methylhistamine dihydrochloride | 6481-48-7 | 1-Methylhistamine diHCl is a histamine metabolite. | |
V82028 | 1-Methylhistamine-d3 dihydrochloride | 344299-49-6 | 1-Methylhistamine-d3 (diHCl) is the deuterium labelled form of 1-Methylhistamine (diHCl). | |
V77330 | 1-Methylinosine-d3 (N1-Methylinosine-d3) | 1-Methylinosine-d3 is the deuterated form of 1-Methylinosine. | ||
V77528 | 1-Methylxanthine-13C,d3 (1-Methylxanthine 13C,d3) | 1-Methylxanthine-13C,d3 is a 13C- and deuterium labelled 1-Methylxanthine. | ||
V72471 | 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | 76343-22-1 | 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine is an endogenously produced metabolite. | |
V72752 | 1-Naphthol-d8 (Furro ER-d8; NSC 9586-d8; Nako TRB-d8) | 207569-03-7 | 1-Naphthol-d8 is the deuterium labelled form of 1-Naphthol. | |
V82045 | 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine (PC(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))) | 132213-85-5 | 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine is an endogenously produced metabolite present in urine and may be utilized to study obesity. | |
V71487 | 1-Octanol-d17 (Octanol-d17) | 153336-13-1 | 1-Octanol-d17 is the deuterated form of 1-Octanol. | |
V70928 | 1-Octanol-d2 (Octanol-d2) | 78510-02-8 | 1-Octanol-d2 is the deuterated form of 1-Octanol. | |
V72567 | 1-Palmitoyl lysophosphatidic acid | 22002-85-3 | 1-Palmitoyl lysophosphatidic acid is a lysophosphatidic acid that causes concentration-dependent aggregation of human platelets. | |
V82067 | 1-Palmitoyl-sn-glycerol 3-phosphate sodium salt (1-P-GPA sodium salt) | 17618-08-5 | 1-Palmitoyl-sn-glycerol 3-phosphate (sodium salt) (1-P-GPA (sodium salt)) is an endogenously produced metabolite. | |
V52753 | 1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol | 2692624-31-8 | 1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol is the deuterated form of 1-Stearoyl-2-arachidonoyl-sn-glycerol. | |
V82008 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine | 35418-59-8 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine is an endogenously produced metabolite. | |
V81850 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol | 1331751-28-0 | 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol is an endogenously produced metabolite and a component of cell membranes. | |
V52522 | 1-Stearoyl-2-arachidonoyl-sn-glycerol | 65914-84-3 | 1-Stearoyl-2-arachidonoyl-sn-glycerol is a diacylglycerol (DAG) containing polyunsaturated fatty acids. |